VESANOID

Vesanoid Adverse Events Reported to the FDA Over Time

How are Vesanoid adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Vesanoid, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Vesanoid is flagged as the suspect drug causing the adverse event.

Most Common Vesanoid Adverse Events Reported to the FDA

What are the most common Vesanoid adverse events reported to the FDA?

Retinoic Acid Syndrome	60 (3.78%)
Pyrexia	47 (2.96%)
Respiratory Failure	20 (1.26%)
Hypoxia	18 (1.13%)
Blood Potassium Increased	17 (1.07%)
Pleural Effusion	17 (1.07%)
Renal Failure	17 (1.07%)
Acute Promyelocytic Leukaemia Diffe...	16 (1.01%)
Pulmonary Alveolar Haemorrhage	16 (1.01%)
Myalgia	15 (.94%)
Neutropenia	15 (.94%)
	Show More
Renal Failure Acute	15 (.94%)
Infection	14 (.88%)
Condition Aggravated	13 (.82%)
Grand Mal Convulsion	13 (.82%)
Pancytopenia	13 (.82%)
Sepsis	13 (.82%)
Confusional State	12 (.76%)
Death	12 (.76%)
Cardiac Failure	11 (.69%)
Disseminated Intravascular Coagulat...	11 (.69%)
Drug Exposure During Pregnancy	11 (.69%)
Hypotension	11 (.69%)
Septic Shock	11 (.69%)
Acute Promyelocytic Leukaemia	10 (.63%)
Anaemia	10 (.63%)
Arthralgia	10 (.63%)
Benign Intracranial Hypertension	10 (.63%)
Diarrhoea	10 (.63%)
Dry Skin	10 (.63%)
Insomnia	10 (.63%)
Interstitial Lung Disease	10 (.63%)
Myocardial Infarction	10 (.63%)
Myositis	10 (.63%)
Blood Creatine Phosphokinase Increa...	9 (.57%)
Cerebral Haemorrhage	9 (.57%)
Dyspnoea	9 (.57%)
Gamma-glutamyltransferase Increased	9 (.57%)
Haemorrhage	9 (.57%)
Myelodysplastic Syndrome	9 (.57%)
Paraesthesia	9 (.57%)
Transaminases Increased	9 (.57%)
Alanine Aminotransferase Increased	8 (.5%)
Aspartate Aminotransferase Increase...	8 (.5%)
Asthenia	8 (.5%)
Blindness Unilateral	8 (.5%)
Cellulitis	8 (.5%)
Embolism	8 (.5%)
Febrile Neutropenia	8 (.5%)
Flushing	8 (.5%)
Headache	8 (.5%)
Phlebitis	8 (.5%)
Platelet Count Decreased	8 (.5%)
Pulmonary Embolism	8 (.5%)
Rash	8 (.5%)
Respiratory Distress	8 (.5%)
Abortion Spontaneous	7 (.44%)
Agitation	7 (.44%)
Alopecia	7 (.44%)
Anxiety	7 (.44%)
Bipolar Disorder	7 (.44%)
Caesarean Section	7 (.44%)
Cerebral Haemorrhage Neonatal	7 (.44%)
Dizziness	7 (.44%)
Fatigue	7 (.44%)
Foetal Distress Syndrome	7 (.44%)
Haemoptysis	7 (.44%)
Histiocytosis Haematophagic	7 (.44%)
Hypercalcaemia	7 (.44%)
Hyperglycaemia	7 (.44%)
Necrotising Ulcerative Gingivostoma...	7 (.44%)
Abdominal Pain	6 (.38%)
Abnormal Behaviour	6 (.38%)
Apgar Score Low	6 (.38%)
Atrioventricular Block Complete	6 (.38%)
Blood Bilirubin Increased	6 (.38%)
Chest Pain	6 (.38%)
Drug Interaction	6 (.38%)
Guillain-barre Syndrome	6 (.38%)
Haemorrhage Intracranial	6 (.38%)
Hyperbilirubinaemia	6 (.38%)
Hypernatraemia	6 (.38%)
Hypoaesthesia	6 (.38%)
Lung Infiltration	6 (.38%)
Nausea	6 (.38%)
Pancreatic Enzymes Increased	6 (.38%)
Pneumonia	6 (.38%)
Suicide Attempt	6 (.38%)
Alveolitis	5 (.31%)
Ascites	5 (.31%)
Blood Alkaline Phosphatase Increase...	5 (.31%)
Blood Lactate Dehydrogenase Increas...	5 (.31%)
Coma	5 (.31%)
Drug Eruption	5 (.31%)
Hepatic Enzyme Increased	5 (.31%)
Medication Error	5 (.31%)
Oliguria	5 (.31%)
Osteonecrosis	5 (.31%)
Premature Baby	5 (.31%)
Progressive Multifocal Leukoencepha...	5 (.31%)
Psychotic Disorder	5 (.31%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Vesanoid, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Vesanoid is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Vesanoid

What are the most common Vesanoid adverse events reported to the FDA?

Respiratory	158 (9.95%)
Infections - Pathogen Unspecified	58 (3.65%)
Body Temperature Conditions	51 (3.21%)
Hepatobiliary	48 (3.02%)
Neurological	47 (2.96%)
Lower Respiratory Tract Disorders	46 (2.9%)
Epidermal And Dermal Conditions	41 (2.58%)
Renal Disorders	38 (2.39%)
Bacterial Infectious	31 (1.95%)
Hematology Investigations	31 (1.95%)
Muscle	31 (1.95%)
	Show More
Central Nervous System Vascular	30 (1.89%)
White Blood Cell	30 (1.89%)
Cardiac Arrhythmias	28 (1.76%)
Enzyme	28 (1.76%)
Anemias Nonhemolytic And Marrow Dep...	25 (1.57%)
Leukemias	24 (1.51%)
Water, Electrolyte And Mineral	24 (1.51%)
Hepatic And Hepatobiliary	23 (1.45%)
Gastrointestinal Signs	21 (1.32%)
Anxiety Disorders	19 (1.2%)
Pleural	19 (1.2%)
Joint	17 (1.07%)
Sleep Disorders	17 (1.07%)
Electrolyte And Fluid Balance Condi...	15 (.94%)
Deliria	14 (.88%)
Seizures	14 (.88%)
Chemical Injury And Poisoning	13 (.82%)
Decreased And Nonspecific Blood Pre...	13 (.82%)
Embolism And Thrombosis	13 (.82%)
Gastrointestinal Motility And Defec...	13 (.82%)
Neonatal And Perinatal Conditions	13 (.82%)
Coagulopathies And Bleeding Diathes...	12 (.76%)
Fatal Outcomes	12 (.76%)
Glucose Metabolism Disorders	12 (.76%)
Medication Errors	12 (.76%)
Physical Examination Topics	12 (.76%)
Vascular	12 (.76%)
Heart Failures	11 (.69%)
Mood Disorders	11 (.69%)
Peripheral Neuropathies	11 (.69%)
Renal And Urinary Tract Investigati...	11 (.69%)
Vascular Inflammations	11 (.69%)
Vision	11 (.69%)
Coronary Artery	10 (.63%)
Gastrointestinal Ulceration And Per...	10 (.63%)
Increased Intracranial Pressure And...	10 (.63%)
Skin Appendage Conditions	10 (.63%)
Vascular Hemorrhagic	10 (.63%)
Bone Disorders	9 (.57%)
Cardiac And Vascular Investigations	9 (.57%)
Fungal Infectious	9 (.57%)
Gastrointestinal Inflammatory Condi...	9 (.57%)
Manic And Bipolar Mood Disorders	9 (.57%)
Obstetric And Gynecological Therape...	9 (.57%)
Oral Soft Tissue Conditions	9 (.57%)
Pericardial	9 (.57%)
Abortions And Stillbirth	8 (.5%)
Bone, Calcium, Magnesium And Phosph...	8 (.5%)
Encephalopathies	8 (.5%)
Headaches	8 (.5%)
Platelet	8 (.5%)
Pulmonary Vascular	8 (.5%)
Skin Vascular Abnormalities	8 (.5%)
Disturbances In Thinking	7 (.44%)
Fetal Complications	7 (.44%)
Hematopoietic Neoplasms	7 (.44%)
Viral Infectious	7 (.44%)
Depressed Mood Disorders	6 (.38%)
Gastrointestinal	6 (.38%)
Movement Disorders	6 (.38%)
Psychiatric And Behavioural Symptom...	6 (.38%)
Suicidal And Self-injurious Behavio...	6 (.38%)
Therapeutic And Nontherapeutic Effe...	6 (.38%)
Metabolic, Nutritional And Blood Ga...	5 (.31%)
Musculoskeletal And Connective Tiss...	5 (.31%)
Peritoneal And Retroperitoneal Cond...	5 (.31%)
Schizophrenia And Other Psychotic	5 (.31%)
Blood And Lymphatic System Disorder...	4 (.25%)
Cardiac Disorder Signs	4 (.25%)
Exocrine Pancreas Conditions	4 (.25%)
Gastrointestinal Hemorrhages	4 (.25%)
Gastrointestinal Neoplasms Malignan...	4 (.25%)
Gastrointestinal Stenosis And Obstr...	4 (.25%)
Lipid Analyses	4 (.25%)
Microbiology And Serology	4 (.25%)
Personality Disorders	4 (.25%)
Reproductive Tract	4 (.25%)
Respiratory Tract Therapeutic Proce...	4 (.25%)
Breast	3 (.19%)
Endocrine Disorders Congenital	3 (.19%)
Hearing	3 (.19%)
Myocardial	3 (.19%)
Protein And Chemistry Analyses	3 (.19%)
Skin And Subcutaneous Tissue	3 (.19%)
Thyroid Gland	3 (.19%)
Arteriosclerosis, Stenosis, Vascula...	2 (.13%)
Aural	2 (.13%)
Bladder And Bladder Neck Disorders	2 (.13%)
Bronchial Disorders	2 (.13%)
Cardiac Valve	2 (.13%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Vesanoid, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Vesanoid is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.